ABILIFY Injection is available in single-dose vials as a ready-to-use, 9.75 mg/1.3 mL (7.5 mg/mL) clear, colorless, sterile, aqueous solution for intramuscular use only. Inactive ingredients for this solution include 199.5mg of sulfobutylether β-cyclodextrin (SBECD), 10.4 mg of tartaric acid...
ABILIFY Injection is available in single-dose vials as a ready-to-use, 9.75 mg/1.3 mL (7.5 mg/mL) clear, colorless, sterile, aqueous solution for intramuscular use only. Inactive ingredients for this solution include 199.5mg of sulfobutylether β-cyclodextrin (SBECD), 10.4 mg of tartaric acid...
Abilify, also known by its generic name aripiprazole, is an antipsychotic medication used to treat mental health conditions such as schizophrenia, bipolar disorder, and major depressive disorder. It is available in various forms, including tablets, orally disintegrating tablets, and oral solution. This...
Applies to aripiprazole: intramuscular powder for injection extended release, intramuscular solution, intramuscular suspension extended release, oral film, oral solution, oral tablet, oral tablet with sensor, oral tablet disintegrating. General adverse events ...
Applies to aripiprazole: intramuscular powder for injection extended release, intramuscular solution, intramuscular suspension extended release, oral film, oral solution, oral tablet, oral tablet with sensor, oral tablet disintegrating. General adverse events ...
initiation of therapy. For patients already stable on another oral antipsychotic (and known to tolerate aripiprazole), after the first ABILIFY MAINTENA injection, continue treatment with the antipsychotic for 14 consecutive days to maintain therapeutic antipsychotic concentrations during initiation of therapy...
ABILIFY® (aripiprazole) Oral Solution (1 mg/mL) is a clear, colorless to light-yellow solution, supplied in child-resistant bottles along with a calibrated oral dosing cup. ABILIFY® (aripiprazole) Injection for Intramuscular Use is a clear, colorless solution available as a ready-to-use,...